BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · SMALL CAP
Cannaisseur Group Inc. TCRG
4 fiscal years on record · USD · FY2025 reported · SEC filings only
$-1.8M
Growth
—
Revenue, FY2025 · full 4-year series below
Revenue $M
Net income $M
FY2025 · Revenue 0.0 · Net income -1.8
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
—
Operating margin
Net margin
FY2024 · Operating -180939.9% · Net -181858.0%
ROE
Not available in our data for this period.
The 4-year record
4 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | · | −0.0 | −0.0 | −0.0 |
| Income tax $B | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −0.03 | −0.03 | 0.00 | 0.00 |
| Dividend / sh $ | · | · | · | · |
| Payout % | · | · | · | · |
| ROE % | · | · | · | · |
| Shares out B | 0.06 | 0.04 | 0.04 | 0.04 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 18 reconciliationsAUDITED
Reconciled in 4 of 19 fiscal years. 77 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company, smaller reporting company
Data on record since2022